D-1087-2015 Class III Terminated
FDA drug recall D-1087-2015 was initiated by Teva Pharmaceuticals USA on May 7, 2015 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: out of specification test results for an impurity during stability testing. The recall status is terminated (terminated Nov 15, 2016). Affected quantity: 233,364 Inhalers.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 3, 2015
- Initiation Date
- May 7, 2015
- Termination Date
- Nov 15, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 233,364 Inhalers
Product description
QVAR (beclomethasone dipropionate HFA 40 mcg), 40 mcg Inhalation Aerosol, For Oral Inhalation with QVAR Actuator Only, 120 metered inhalations, Rx Only, Mktd by Teva Respiratory, LLC., Horsham, PA. mfd by 3M Drug Delivery Systems, Northridge, CA, NDC 59310-0202-12
Reason for recall
Failed Impurities/Degradation Specifications: out of specification test results for an impurity during stability testing.
Distribution pattern
Nationwide and Peurto Rico
Code information
Lot #s:130449, 130450; Exp. Date: 12/2015
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1087-2015
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026